Enrico Derenzini

26PUBLICATIONS
152CO-AUTHORS
HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Aug 22, 2026
Mitigating HLA Disparity in AML Transplantation: Comparable Outcomes After Haploidentical and 9/10 Mismatched Unrelated Donor Transplantation With Treosulfan and PTCy.

|Aug 17, 2026
Venetoclax in Combination With Chemo-Immunotherapy in Richter Transformation: A Real-Life Experience.

|Feb 11, 2026
Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm.

Naveen Pemmaraju, Giovanni Marconi, Pau Montesinos

|Jan 14, 2026
TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient Journey.

Lisa Argnani, Cinzia Pellegrini, Ombretta Annibali

|Jan 07, 2026
Real-world safety and effectiveness of zanubrutinib vs ibrutinib in CLL: the CLL-ZANU2024 Italian cohort.

Enrica Antonia Martino, Annalisa Pitino, Ernesto Vigna

|Dec 29, 2025
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World Study.

Ernesto Vigna, Enrica Antonia Martino, Annalisa Pitino

Pageof 5

Frequent Collaborators

3 joint publications

Isacco Ferrarini

3 joint publications

Anna Maria Frustaci

3 joint publications

Valentina Tabanelli

3 joint publications

Roberto Marasca